Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation.

Walter, R B; Gyurkocza, B; Storer, B E; Godwin, C D; Pagel, J M; Buckley, S A; Sorror, M L; Wood, B L; Storb, R; Appelbaum, F R; Sandmaier, B M

Walter, R B; Gyurkocza, B; Storer, B E; Godwin, C D; Pagel, J M; Buckley, S A; Sorror, M L; Wood, B L; Storb, R; Appelbaum, F R; Sandmaier, B M.

Afiliação

Walter RB; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Department of Epidemiology, University of Washington, Seattle, WA, USA.
Gyurkocza B; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Storer BE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Godwin CD; Department of Medicine, Residency Program, University of Washington, Seattle, WA, USA.
Pagel JM; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Buckley SA; Department of Medicine, Residency Program, University of Washington, Seattle, WA, USA.
Sorror ML; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Wood BL; Division of Hematopathology, Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Storb R; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Appelbaum FR; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Sandmaier BM; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

Leukemia ; 29(1): 137-44, 2015 Jan.

Article em En | MEDLINE | ID: mdl-24888275

Assuntos

Transplante de Células-Tronco Hematopoéticas; Leucemia Mieloide Aguda/terapia; Neoplasia Residual; Indução de Remissão; Condicionamento Pré-Transplante; Adulto; Idoso; Feminino; Doença Enxerto-Hospedeiro; Humanos; Masculino; Pessoa de Meia-Idade; Prognóstico; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indução de Remissão / Leucemia Mieloide Aguda / Neoplasia Residual / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google